Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate

November 21, 2024

Conference Call and Webcast Details


The dial-in numbers for Protagonist's investor update on Thursday, November 21st at 4:30 pm ET are:

US-based Investors: 1-877-407-0752

International Investors: 1-201-389-0912

Conference Call ID: 13750274

Webcast Link >

DOWNLOAD PRESENTATION